Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
Aclaris Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -134.65M | -130.21M | -132.06M | -37M | -58.68M | -77.26M | -88.48M | -114.63M | -105.32M | -96.28M | -86.91M | -82.08M | -83.27M | -80.9M | -90.86M | -81.23M | -70.75M | -64.18M |
Depreciation & Amortization | 606K | 734K | 849K | 934K | 932K | 908K | 863K | 825K | 799K | 787K | 797K | 804K | 802K | 843K | 923K | 277K | 677K | 1.04M |
Stock-Based Compensation | 12.46M | 12.3M | 10.86M | 9.26M | 12.21M | 15.82M | 20.54M | 24.09M | 22.33M | 19.5M | 15.04M | 14.08M | 13.59M | 13.73M | 14.06M | 12.71M | 10.95M | 10.43M |
Other Working Capital | 21.77M | 22.33M | 15.13M | 26.8M | 474K | 1.85M | 10.68M | -9.33M | -4.68M | -2.08M | -1.7M | 1.61M | 346K | -2.13M | 119.53M | 165.21M | 208.14M | 261.03M |
Other Non-Cash Items | 88.16M | 86.86M | 89.36M | -22.54M | -20.96M | -22.86M | -26.46M | 6.94M | 6.8M | 5.1M | 4.7M | -200K | -1.5M | 6.7M | 24.34M | 22.19M | 21.91M | 15.4M |
Deferred Income Tax | n/a | n/a | n/a | 6.26M | 5.63M | 5.83M | 5.83M | -437K | 198K | n/a | n/a | n/a | 752K | 752K | 752K | 570K | -182K | -182K |
Change in Working Capital | 23.43M | 17.99M | 10.92M | 25.19M | -3.58M | 4.78M | 9.39M | -7.47M | 1.25M | -2.06M | -1.2M | 1.87M | 1.31M | -2M | -1.34M | 1.62M | -8.03M | -8.22M |
Operating Cash Flow | -9.99M | -12.32M | -20.07M | -17.9M | -64.45M | -72.79M | -78.33M | -90.68M | -73.94M | -72.95M | -67.57M | -65.53M | -68.32M | -60.87M | -52.13M | -43.92M | -45.46M | -44.06M |
Capital Expenditures | -35.87M | -35.84M | -35.93M | -562K | -646K | -891K | -1.31M | -973K | -1.04M | -994K | -605K | -700K | -606K | -472K | -308K | -116K | -364K | -329K |
Cash Acquisitions | n/a | n/a | n/a | n/a | -32.62M | -13.19M | -39.54M | -42.34M | -11.09M | -9.49M | 16.86M | 19.62M | 20.98M | -52K | -52K | n/a | n/a | n/a |
Purchase of Investments | -114.69M | -129.98M | -119.98M | -49.55M | -52.38M | -107.15M | -135.68M | -181.7M | -198.17M | -178.72M | -164.75M | -154.02M | -172.96M | -163.9M | -235.15M | -207.68M | -167.86M | -124.66M |
Sales Maturities Of Investments | 89.64M | 99.17M | 86.14M | 76.62M | 109.27M | 145.3M | 183.2M | 224.04M | 209.26M | 188.21M | 177.99M | 155.47M | 135.43M | 101.98M | 67.83M | 47.03M | 50.38M | 42.12M |
Other Investing Acitivies | -833K | -833K | n/a | n/a | 32.62M | 13.19M | 39.54M | 42.34M | 11.09M | 9.49M | 13.23M | 10.48M | -28.5M | -52.89M | -158.3M | -160.65M | -117.49M | -82.54M |
Investing Cash Flow | -61.76M | -67.48M | -69.77M | 26.5M | 56.24M | 37.26M | 46.22M | 41.37M | 10.05M | 8.49M | 12.63M | 750K | -38.14M | -62.39M | -167.63M | -160.76M | -117.85M | -82.87M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.48M | -11.48M | -11.48M | -11.49M | -45K | -117K |
Common Stock Repurchased | -618K | -629K | -409K | -76K | -66K | -55K | n/a | n/a | -11K | -11K | -18K | -20K | -93K | -93K | -86K | 7.65M | 7.74M | 7.71M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | -25K | -25K |
Other Financial Acitivies | -352K | -343K | -343K | -10K | -102K | 26.64M | 26.64M | 26.68M | 26.77M | 93K | 123K | 84K | 95K | 1.05M | -1.58M | 6.26M | 6.02M | 4.97M |
Financial Cash Flow | 74.32M | 74.32M | 74.54M | 5K | -104K | 26.65M | 26.71M | 26.69M | 26.77M | 72.84M | 72.87M | 72.83M | 61.27M | 124.33M | 225.05M | 232.88M | 244.17M | 108.2M |
Net Cash Flow | 2.57M | -5.48M | -15.31M | 8.61M | -8.32M | -8.88M | -5.4M | -22.61M | -37.11M | 8.38M | 17.93M | 8.05M | -45.18M | 1.07M | 5.29M | 28.21M | 80.86M | -18.73M |
Free Cash Flow | -45.86M | -48.16M | -56.01M | -18.46M | -65.1M | -73.68M | -79.63M | -91.65M | -74.98M | -73.94M | -68.17M | -66.23M | -68.92M | -61.34M | -52.44M | -44.03M | -45.82M | -44.39M |